Urinary metabolomic profiling of patients with glioblastoma multiforme

Journal of Proteomics and Bioinformatics

Volumn 6, Issue 7, 2013, Pages

  Tandle, Anita T ^a   Shankavaram, Uma ^a   Brown, Meredith V ^b   Ho, Jennifer ^a   Graves, Christian ^a   Lita, Elena ^a   Pfohl, Jeff ^b   Mohney, Robert ^b   Tofilon, Philip ^a   Camphausen, Kevin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b METABOLON INC   (United States)

Author keywords

GC MS MS; Glioblastoma multiforme; LC MS MS; Metabolomic profiling; Radiation; Urine

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; BRAIN RADIATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CITRIC ACID CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS FRAGMENTOGRAPHY; METABOLITE; METABOLOMICS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION EXPOSURE; RADIATION RESPONSE; SURVIVAL TIME; URINALYSIS;

EID: 84881560426     PISSN: None     EISSN: 0974276X     Source Type: Journal    
DOI: 10.4172/jpb.S6-003     Document Type: Article

References (36)

1. Madsen R, Lundstedt T, Trygg J (2010) Chemometrics in metabolomics--a review in human disease diagnosis. Anal Chim Acta 659: 23-33.
2. Vinayavekhin N, Homan EA, Saghatelian A (2010) Exploring disease through metabolomics. ACS Chem Biol 5: 91-103.
3. Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, et al. (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 69: 4918-4925.
4. Hu JD, Tang HQ, Zhang Q, Fan J, Hong J, et al. (2011) Prediction of gastric cancer metastasis through urinary metabolomic investigation using GC/MS. World J Gastroenterol 17: 727-734.
5. Kim K, Aronov P, Zakharkin SO, Anderson D, Perroud B, et al. (2009) Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol Cell Proteomics 8: 558-570.
6. Kind T, Tolstikov V, Fiehn O, Weiss RH (2007) A comprehensive urinary metabolomic approach for identifying kidney cancerr. Anal Biochem 363: 185-195.
7. Mal M, Koh PK, Cheah PY, Chan EC (2009) Development and validation of a gas chromatography/mass spectrometry method for the metabolic profiling of human colon tissue. Rapid Commun Mass Spectrom 23: 487-494.
8. Monleón D, Morales JM, Barrasa A, López JA, Vázquez C, et al. (2009) Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed 22: 342-348.
9. Qiu Y, Cai G, Su M, Chen T, Liu Y, et al. (2010) Urinary metabonomic study on colorectal cancer. J Proteome Res 9: 1627-1634.
10. Qiu Y, Cai G, Su M, Chen T, Zheng X, et al. (2009) Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res 8: 4844-4850.
11. Tan C, Chen H, Xia C (2009) Early prediction of lung cancer based on the combination of trace element analysis in urine and an Adaboost algorithm. J Pharm Biomed Anal 49: 746-752.
12. Wu H, Xue R, Lu C, Deng C, Liu T, et al. (2009) Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 877: 3111-3117.
13. Jonsson P, Johansson AI, Gullberg J, Trygg J, A J, et al. (2005) High-throughput data analysis for detecting and identifying differences between samples in GC/ MS-based metabolomic analyses. Anal Chem 77: 5635-5642.
14. Jonsson P, Gullberg J, Nordström A, Kusano M, Kowalczyk M, et al. (2004) A strategy for identifying differences in large series of metabolomic samples analyzed by GC/MS. Anal Chem 76: 1738-1745.
15. Kirk MJ, Hayward RM, Sproull M, Scott T, Smith S, et al. (2008) Non-patient related variables affecting levels of vascular endothelial growth factor in urine biospecimens. J Cell Mol Med 12: 1250-1255.
16. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E (2009) Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 81: 6656-6667.
17. Dehaven CD, Evans AM, Dai H, Lawton KA (2010) Organization of GC/MS and LC/MS metabolomics data into chemical libraries. J Cheminform 2: 9.
18. Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100: 9440-9445.
19. Masica DL, Karchin R (2011) Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival. Cancer Res 71: 4550-4561.
20. McDowell KA, Riggins GJ, Gallia GL (2011) Targeting the AKT pathway in glioblastoma. Curr Pharm Des 17: 2411-2420.
21. Rekers NH, Sminia P, Peters GJ (2011) Towards tailored therapy of glioblastoma multiforme. J Chemother 23: 187-199.
22. Brennan C (2011) Genomic profiles of glioma. Curr Neurol Neurosci Rep 11: 291-297.
23. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N et al. (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352: 997-1003.
24. Borodovsky A, Seltzer MJ, Riggins GJ (2012) Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2. Curr Opin Oncol 24: 83-89.
25. Chinnaiyan P, Kensicki E, Bloom G, Prabhu A, Sarcar B, et al. (2012) The metabolomic signature of malignant glioma reflects accelerated anabolic metabolism. Cancer Res 72: 5878-5888.
26. Wibom C, Surowiec I, Mörén L, Bergström P, Johansson M, et al. (2010) Metabolomic patterns in glioblastoma and changes during radiotherapy: a clinical microdialysis study. J Proteome Res 9: 2909-2919.
27. Dell' Antone P (2012) Energy metabolism in cancer cells: how to explain the Warburg and Crabtree effects? Med Hypotheses 79: 388-392.
28. Marin-Valencia I, Yang C, Mashimo T, Cho S, Baek H, et al. (2012) Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell Metab 15: 827-837.
29. Wise DR, Thompson CB (2010) Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci 35: 427-433.
30. Endersby R, Baker SJ (2008) PTEN signaling in brain: neuropathology and tumorigenesis. Oncogene 27: 5416-5430.
31. Houillier C, Lejeune J, Benouaich-Amiel A, Laigle-Donadey F, Criniere E, et al. (2006) Prognostic impact of molecular markers in a series of 220 primary glioblastomas. Cancer 106: 2218-2223.
32. Zoncu R, Efeyan A, Sabatini DM (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12: 21-35.
33. Hahn-Windgassen A, Nogueira V, Chen CC, Skeen JE, Sonenberg N, et al. (2005) Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J Biol Chem 280: 32081-32089.
34. Johnson CH, Patterson AD, Krausz KW, Lanz C, Kang DW, et al. (2011) Radiation metabolomics. 4. UPLC-ESI-QTOFMS-Based metabolomics for urinary biomarker discovery in gamma-irradiated rats. Radiat Res 175: 473-484.
35. Tyburski JB, Patterson AD, Krausz KW, Slavík J, Fornace AJ Jr, et al. (2009) Radiation metabolomics. 2. Dose- and time-dependent urinary excretion of deaminated purines and pyrimidines after sublethal gamma-radiation exposure in mice. Radiat Res 172: 42-57.
36. Lee do Y, Bowen BP, Nguyen DH, Parsa S, Huang Y, et al. (2012) Low-dose ionizing radiation-induced blood plasma metabolic response in a diverse genetic mouse population. Radiat Res 178: 551-555.